These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24331186)

  • 1. Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.
    Walker AJ; Alcorn SR; Narang AK; Nugent KM; Wild AT; Herman JM; Tran PT
    Curr Probl Cancer; 2013; 37(5):301-12. PubMed ID: 24331186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy.
    Searle EJ; Illidge TM; Stratford IJ
    Clin Oncol (R Coll Radiol); 2014 May; 26(5):266-76. PubMed ID: 24602563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.
    Alcorn S; Walker AJ; Gandhi N; Narang A; Wild AT; Hales RK; Herman JM; Song DY; Deweese TL; Antonarakis ES; Tran PT
    Int J Mol Sci; 2013 Jul; 14(7):14800-32. PubMed ID: 23863691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.
    Lin SH; George TJ; Ben-Josef E; Bradley J; Choe KS; Edelman MJ; Guha C; Krishnan S; Lawrence TS; Le QT; Lu B; Mehta M; Peereboom D; Sarkaria J; Seong J; Wang D; Welliver MX; Coleman CN; Vikram B; Yoo S; Chung CH; ;
    J Natl Cancer Inst; 2013 May; 105(10):686-93. PubMed ID: 23503600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel chemoradiosensitizers for cancer therapy.
    Page P; Yang LX
    Anticancer Res; 2010 Sep; 30(9):3675-82. PubMed ID: 20944153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review.
    Zagouri F; Sergentanis TN; Chrysikos D; Zografos CG; Papadimitriou CA; Dimopoulos MA; Filipits M; Bartsch R
    Pancreas; 2013 Jul; 42(5):760-73. PubMed ID: 23774698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concurrent chemoradiation therapy with gemcitabine for advanced or relapsed pancreatic tumors].
    Ioka T; Nakaizumi A; Tanaka S; Yamazaki H; Nishiyama K
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():248-53. PubMed ID: 16457260
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of Radiosensitizers in Cancer Radiotherapy.
    Gong L; Zhang Y; Liu C; Zhang M; Han S
    Int J Nanomedicine; 2021; 16():1083-1102. PubMed ID: 33603370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell-directed therapies in pancreatic cancer.
    Kumar R; Dholakia A; Rasheed Z
    Curr Probl Cancer; 2013; 37(5):280-6. PubMed ID: 24331183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for a stratified application of targeted agents against pancreatic cancer.
    Bijlsma MF
    EBioMedicine; 2021 May; 67():103344. PubMed ID: 33910122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1461-7. PubMed ID: 11681259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-directed drug strategies to target the tumor microenvironment.
    Hay MP; Hicks KO; Wang J
    Adv Exp Med Biol; 2014; 772():111-45. PubMed ID: 24272357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy and molecular-targeted agents in preclinical testing for immunotherapy, brain tumors, and sarcomas: Opportunities and challenges.
    Vatner R; James CD; Sathiaseelan V; Bondra KM; Kalapurakal JA; Houghton PJ
    Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28439. PubMed ID: 32827353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
    Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
    J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies.
    Waissi W; Paix A; Nicol A; Noël G; Burckel H
    Crit Rev Oncol Hematol; 2020 Sep; 153():103060. PubMed ID: 32707435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.
    Coleman CN; Higgins GS; Brown JM; Baumann M; Kirsch DG; Willers H; Prasanna PG; Dewhirst MW; Bernhard EJ; Ahmed MM
    Clin Cancer Res; 2016 Jul; 22(13):3138-47. PubMed ID: 27154913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's new in pancreatic cancer treatment?
    Fung MC; Sakata T
    J Hepatobiliary Pancreat Surg; 2002; 9(1):61-75. PubMed ID: 12021899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel as a radiation sensitizer for locally advanced pancreatic cancer.
    Safran H; Rathore R
    Crit Rev Oncol Hematol; 2002 Jul; 43(1):57-62. PubMed ID: 12098607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and Non-Targeted Mechanisms for Killing Hypoxic Tumour Cells-Are There New Avenues for Treatment?
    Apilan AG; Mothersill C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer.
    Millar BC
    Biochem Pharmacol; 1982 Aug; 31(15):2439-45. PubMed ID: 6751333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.